1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global COVID-19 Inactivated Vaccine Market Size Growth Rate by Type (2021-2027) 1.2.2 In Clinical Trials 1.2.3 Out-of-Clinical Trials 1.3 Market by Application 1.3.1 Global COVID-19 Inactivated Vaccine Market Share by Application (2021-2027) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global COVID-19 Inactivated Vaccine Market Size 2.2 COVID-19 Inactivated Vaccine Market Size by Regions 2.2.1 COVID-19 Inactivated Vaccine Growth Rate by Regions (2021-2027) 2.2.2 COVID-19 Inactivated Vaccine Market Share by Regions (2021-2027) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Use Cases 3 Key Players 3.1 COVID-19 Inactivated Vaccine Revenue by Players (2020-2021) 3.2 COVID-19 Inactivated Vaccine Key Players Headquaters and Area Served 3.3 Key Players COVID-19 Inactivated Vaccine Product/Solution/Service 3.4 Date of Enter into COVID-19 Inactivated Vaccine Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown by Type and by Application 4.1 Global COVID-19 Inactivated Vaccine Market Size by Type (2021-2027) 4.2 Global COVID-19 Inactivated Vaccine Market Size by Application (2021-2027) 5 North America 5.1 North America COVID-19 Inactivated Vaccine Market Forecast (2021-2027) 5.2 COVID-19 Inactivated Vaccine Key Players in North America 5.3 North America COVID-19 Inactivated Vaccine Market Size by Type 5.4 North America COVID-19 Inactivated Vaccine Market Size by Application 6.4.4 Canada 6 Europe 6.1 Europe COVID-19 Inactivated Vaccine Market Forecast (2021-2027) 6.2 COVID-19 Inactivated Vaccine Key Players in Europe 6.3 Europe COVID-19 Inactivated Vaccine Market Size by Type 6.4 Europe COVID-19 Inactivated Vaccine Market Size by Application 7 Japan 7.1 Japan COVID-19 Inactivated Vaccine Market Forecast (2021-2027) 7.2 COVID-19 Inactivated Vaccine Key Players in Europe 7.3 Japan COVID-19 Inactivated Vaccine Market Size by Type 7.4 Japan COVID-19 Inactivated Vaccine Market Size by Application 8 Rest of World 8.1 China 8.1.1 China COVID-19 Inactivated Vaccine Market Analysis 8.1.2 Key Players in China 8.2 Southeast Asia 8.2.1 Southeast Asia COVID-19 Inactivated Vaccine Market Analysis 8.2.2 Key Players in Southeast Asia 8.3 India 8.3.1 India COVID-19 Inactivated Vaccine Market Analysis 8.3.2 Key Players in India 9 International Player Profiles 9.1 Inovio Pharmaceuticals 9.1.1 Inovio Pharmaceuticals Company Details 9.1.2 Inovio Pharmaceuticals Description and Business Overview 9.1.3 Inovio Pharmaceuticals COVID-19 Inactivated Vaccine Introduction 9.1.4 Inovio Pharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.1.5 Inovio Pharmaceuticals Recent Development 9.2 Takis Biotech (Evvivax) 9.2.1 Takis Biotech (Evvivax) Company Details 9.2.2 Takis Biotech (Evvivax) Description and Business Overview 9.2.3 Takis Biotech (Evvivax) COVID-19 Inactivated Vaccine Introduction 9.2.4 Takis Biotech (Evvivax) Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.2.5 Takis Biotech (Evvivax) Recent Development 9.3 Zydus Cadila 9.3.1 Zydus Cadila Company Details 9.3.2 Zydus Cadila Description and Business Overview 9.3.3 Zydus Cadila COVID-19 Inactivated Vaccine Introduction 9.3.4 Zydus Cadila Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.3.5 Zydus Cadila Recent Development 9.4 Codagenix, Inc. 9.4.1 Codagenix, Inc. Company Details 9.4.2 Codagenix, Inc. Description and Business Overview 9.4.3 Codagenix, Inc. COVID-19 Inactivated Vaccine Introduction 9.4.4 Codagenix, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.4.5 Codagenix, Inc. Recent Development 9.5 GeoVax, Inc. 9.5.1 GeoVax, Inc. Company Details 9.5.2 GeoVax, Inc. Description and Business Overview 9.5.3 GeoVax, Inc. COVID-19 Inactivated Vaccine Introduction 9.5.4 GeoVax, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.5.5 GeoVax, Inc. Recent Development 9.6 Bravovax 9.6.1 Bravovax Company Details 9.6.2 Bravovax Description and Business Overview 9.6.3 Bravovax COVID-19 Inactivated Vaccine Introduction 9.6.4 Bravovax Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.6.5 Bravovax Recent Development 9.7 Janssen Pharmaceutical Companies 9.7.1 Janssen Pharmaceutical Companies Company Details 9.7.2 Janssen Pharmaceutical Companies Description and Business Overview 9.7.3 Janssen Pharmaceutical Companies COVID-19 Inactivated Vaccine Introduction 9.7.4 Janssen Pharmaceutical Companies Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.7.5 Janssen Pharmaceutical Companies Recent Development 9.8 Altimmune 9.8.1 Altimmune Company Details 9.8.2 Altimmune Description and Business Overview 9.8.3 Altimmune COVID-19 Inactivated Vaccine Introduction 9.8.4 Altimmune Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.8.5 Altimmune Recent Development 9.9 Vaxart 9.9.1 Vaxart Company Details 9.9.2 Vaxart Description and Business Overview 9.9.3 Vaxart COVID-19 Inactivated Vaccine Introduction 9.9.4 Vaxart Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.9.5 Vaxart Recent Development 9.10 CanSino Biologics 9.10.1 CanSino Biologics Company Details 9.10.2 CanSino Biologics Description and Business Overview 9.10.3 CanSino Biologics COVID-19 Inactivated Vaccine Introduction 9.10.4 CanSino Biologics Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.10.5 CanSino Biologics Recent Development 9.11 ExpreS2ion Biotechnologies ApS 9.11.1 ExpreS2ion Biotechnologies ApS Company Details 9.11.2 ExpreS2ion Biotechnologies ApS Description and Business Overview 9.11.3 ExpreS2ion Biotechnologies ApS COVID-19 Inactivated Vaccine Introduction 9.11.4 ExpreS2ion Biotechnologies ApS Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.11.5 ExpreS2ion Biotechnologies ApS Recent Development 9.12 Clover Biopharmaceuticals 9.12.1 Clover Biopharmaceuticals Company Details 9.12.2 Clover Biopharmaceuticals Description and Business Overview 9.12.3 Clover Biopharmaceuticals COVID-19 Inactivated Vaccine Introduction 9.12.4 Clover Biopharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.12.5 Clover Biopharmaceuticals Recent Development 9.13 GSK 9.13.1 GSK Company Details 9.13.2 GSK Description and Business Overview 9.13.3 GSK COVID-19 Inactivated Vaccine Introduction 9.13.4 GSK Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.13.5 GSK Recent Development 9.14 Vaxil Bio Ltd. 9.14.1 Vaxil Bio Ltd. Company Details 9.14.2 Vaxil Bio Ltd. Description and Business Overview 9.14.3 Vaxil Bio Ltd. COVID-19 Inactivated Vaccine Introduction 9.14.4 Vaxil Bio Ltd. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.14.5 Vaxil Bio Ltd. Recent Development 9.15 Generex 9.15.1 Generex Company Details 9.15.2 Generex Description and Business Overview 9.15.3 Generex COVID-19 Inactivated Vaccine Introduction 9.15.4 Generex Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.15.5 Generex Recent Development 9.16 Novavax, Inc. 9.16.1 Company Details 9.16.2 Novavax, Inc. Description and Business Overview 9.16.3 Novavax, Inc. COVID-19 Inactivated Vaccine Introduction 9.16.4 Novavax, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.16.5 Novavax, Inc. Recent Development 9.17 Sanofi Pasteur 9.17.1 Sanofi Pasteur Company Details 9.17.2 Sanofi Pasteur Description and Business Overview 9.17.3 Sanofi Pasteur COVID-19 Inactivated Vaccine Introduction 9.17.4 Sanofi Pasteur Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.17.5 Sanofi Pasteur Recent Development 9.18 Baylor 9.18.1 Baylor Company Details 9.18.2 Baylor Description and Business Overview 9.18.3 Baylor COVID-19 Inactivated Vaccine Introduction 9.18.4 Baylor Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.18.5 Baylor Recent Development 9.19 iBio, Inc. 9.19.1 iBio, Inc. Company Details 9.19.2 iBio, Inc. Description and Business Overview 9.19.3 iBio, Inc. COVID-19 Inactivated Vaccine Introduction 9.19.4 iBio, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.19.5 iBio, Inc. Recent Development 9.20 Moderna, Inc. 9.20.1 Moderna, Inc. Company Details 9.20.2 Moderna, Inc. Description and Business Overview 9.20.3 Moderna, Inc. COVID-19 Inactivated Vaccine Introduction 9.20.4 Moderna, Inc. Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.20.5 Moderna, Inc. Recent Development 9.21 Curevac 9.21.1 Curevac Company Details 9.21.2 Curevac Description and Business Overview 9.21.3 Curevac COVID-19 Inactivated Vaccine Introduction 9.21.4 Curevac Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.21.5 Curevac Recent Development 9.22 ImmunoPrecise 9.22.1 ImmunoPrecise Company Details 9.22.2 ImmunoPrecise Description and Business Overview 9.22.3 ImmunoPrecise COVID-19 Inactivated Vaccine Introduction 9.22.4 ImmunoPrecise Revenue in COVID-19 Inactivated Vaccine Business (2020-2021) 9.22.5 ImmunoPrecise Recent Development 10 Market Dynamics 10.1 Industry Trends 10.2 Market Drives 10.3 Market Challenges 10.4 Market Restraints 11 Key Findings in This Report 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.2 Data Source 12.2 Disclaimer 12.3 Author Details

List of Tables Table 1. Global COVID-19 Inactivated Vaccine Market Size Growth Rate by Type (2021-2027) (US$ Million) Table 2. Key Players of In Clinical Trials Table 3. Key Players of Out-of-Clinical Trials Table 4. Global COVID-19 Inactivated Vaccine Market Size Growth by Application (2021-2027) (US$ Million) Table 5. Global COVID-19 Inactivated Vaccine Market Size by Regions (2021-2027) (US$ Million) Table 6. Global COVID-19 Inactivated Vaccine Market Share by Regions (2021-2027) Table 7. Market Top Trends Table 8. Market Use Cases Table 9. Global COVID-19 Inactivated Vaccine Revenue by Players (2020-2021) (US$ Million) Table 10. Global COVID-19 Inactivated Vaccine Market Share by Players (2020-2021) Table 11. Key Players Headquarters and Area Served Table 12. Key Players COVID-19 Inactivated Vaccine Product Solution and Service Table 13. Date of Enter into COVID-19 Inactivated Vaccine Market Table 14. Mergers & Acquisitions, Expansion Plans Table 15. Global COVID-19 Inactivated Vaccine Market Size by Type (2021-2027) (US$ Million) Table 16. Global COVID-19 Inactivated Vaccine Market Size Share by Type (2021-2027) Table 17. Global COVID-19 Inactivated Vaccine Market Size by Application (2021-2027) (US$ Million) Table 18. Global COVID-19 Inactivated Vaccine Market Size Share by Application (2021-2027) Table 19. North America Key Players COVID-19 Inactivated Vaccine Revenue (2020-2021) (US$ Million) Table 20. North America Key Players COVID-19 Inactivated Vaccine Market Share (2020-2021) Table 21. North America COVID-19 Inactivated Vaccine Market Size by Type (2021-2027) (US$ Million) Table 22. North America COVID-19 Inactivated Vaccine Market Share by Type (2021-2027) Table 23. North America COVID-19 Inactivated Vaccine Market Size by Application (2021-2027) (US$ Million) Table 24. North America COVID-19 Inactivated Vaccine Market Share by Application (2021-2027) Table 25. Europe Key Players COVID-19 Inactivated Vaccine Revenue (2020-2021) (US$ Million) Table 26. Europe Key Players COVID-19 Inactivated Vaccine Market Share (2020-2021) Table 27. Europe COVID-19 Inactivated Vaccine Market Size by Type (2021-2027) (US$ Million) Table 28. Europe COVID-19 Inactivated Vaccine Market Share by Type (2021-2027) Table 29. Europe COVID-19 Inactivated Vaccine Market Size by Application (2021-2027) (US$ Million) Table 30. Europe COVID-19 Inactivated Vaccine Market Share by Application (2021-2027) Table 31. Japan Key Players COVID-19 Inactivated Vaccine Revenue (2020-2021) (US$ Million) Table 32. Japan Key Players COVID-19 Inactivated Vaccine Market Share (2020-2021) Table 33. Japan COVID-19 Inactivated Vaccine Market Size by Type (2021-2027) (US$ Million) Table 34. Japan COVID-19 Inactivated Vaccine Market Share by Type (2021-2027) Table 35. Japan COVID-19 Inactivated Vaccine Market Size by Application (2021-2027) (US$ Million) Table 36. Japan COVID-19 Inactivated Vaccine Market Share by Application (2021-2027) Table 37. Key Players in China Table 38. Key Players in Southeast Asia Table 39. Key Players in India Table 40. Inovio Pharmaceuticals Company Details Table 41. Inovio Pharmaceuticals Description and Business Overview Table 42. Inovio Pharmaceuticals COVID-19 Inactivated Vaccine Product Table 43. Inovio Pharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 44. Inovio Pharmaceuticals Recent Development Table 45. Takis Biotech (Evvivax) Company Details Table 46. Takis Biotech (Evvivax) Description and Business Overview Table 47. Takis Biotech (Evvivax) COVID-19 Inactivated Vaccine Product Table 48. Takis Biotech (Evvivax) Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 49. Takis Biotech (Evvivax) Recent Development Table 50. Zydus Cadila Company Details Table 51. Zydus Cadila Description and Business Overview Table 52. Zydus Cadila COVID-19 Inactivated Vaccine Product Table 53. Zydus Cadila Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 54. Zydus Cadila Recent Development Table 55. Codagenix, Inc. Company Details Table 56. Codagenix, Inc. Description and Business Overview Table 57. Codagenix, Inc. COVID-19 Inactivated Vaccine Product Table 58. Codagenix, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 59. Codagenix, Inc. Recent Development Table 60. GeoVax, Inc. Company Details Table 61. GeoVax, Inc. Description and Business Overview Table 62. GeoVax, Inc. COVID-19 Inactivated Vaccine Product Table 63. GeoVax, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 64. GeoVax, Inc. Recent Development Table 65. Bravovax Company Details Table 66. Bravovax Description and Business Overview Table 67. Bravovax COVID-19 Inactivated Vaccine Product Table 68. Bravovax Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 69. Bravovax Recent Development Table 70. Janssen Pharmaceutical Companies Company Details Table 71. Janssen Pharmaceutical Companies Description and Business Overview Table 72. Janssen Pharmaceutical Companies COVID-19 Inactivated Vaccine Product Table 73. Janssen Pharmaceutical Companies Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 74. Janssen Pharmaceutical Companies Recent Development Table 75. Altimmune Company Details Table 76. Altimmune Description and Business Overview Table 77. Altimmune COVID-19 Inactivated Vaccine Product Table 78. Altimmune Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 79. Altimmune Recent Development Table 80. Vaxart Company Details Table 81. Vaxart Description and Business Overview Table 82. Vaxart COVID-19 Inactivated Vaccine Product Table 83. Vaxart Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 84. Vaxart Recent Development Table 85. CanSino Biologics Company Details Table 86. CanSino Biologics Description and Business Overview Table 87. CanSino Biologics COVID-19 Inactivated Vaccine Product Table 88. CanSino Biologics Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 89. CanSino Biologics Recent Development Table 90. ExpreS2ion Biotechnologies ApS Company Details Table 91. ExpreS2ion Biotechnologies ApS Description and Business Overview Table 92. ExpreS2ion Biotechnologies ApS COVID-19 Inactivated Vaccine Product Table 93. ExpreS2ion Biotechnologies ApS Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 94. ExpreS2ion Biotechnologies ApS Recent Development Table 95. Clover Biopharmaceuticals Company Details Table 96. Clover Biopharmaceuticals Description and Business Overview Table 97. Clover Biopharmaceuticals COVID-19 Inactivated Vaccine Product Table 98. Clover Biopharmaceuticals Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 99. Clover Biopharmaceuticals Recent Development Table 100. GSK Company Details Table 101. GSK Description and Business Overview Table 102. GSK COVID-19 Inactivated Vaccine Product Table 103. GSK Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 104. GSK Recent Development Table 105. Vaxil Bio Ltd. Company Details Table 106. Vaxil Bio Ltd. Description and Business Overview Table 107. Vaxil Bio Ltd. COVID-19 Inactivated Vaccine Product Table 108. Vaxil Bio Ltd. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 109. Vaxil Bio Ltd. Recent Development Table 110. Generex Company Details Table 111. Generex Description and Business Overview Table 112. Generex COVID-19 Inactivated Vaccine Product Table 113. Generex Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 114. Generex Recent Development Table 115. Novavax, Inc. Company Details Table 116. Novavax, Inc. Description and Business Overview Table 117. Novavax, Inc. COVID-19 Inactivated Vaccine Product Table 118. Novavax, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 119. Novavax, Inc. Recent Development Table 120. Sanofi Pasteur Company Details Table 121. Sanofi Pasteur Description and Business Overview Table 122. Sanofi Pasteur COVID-19 Inactivated Vaccine Product Table 123. Sanofi Pasteur Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 124. Sanofi Pasteur Recent Development Table 125. Baylor Company Details Table 126. Baylor Description and Business Overview Table 127. Baylor COVID-19 Inactivated Vaccine Product Table 128. Baylor Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 129. Baylor Recent Development Table 130. iBio, Inc. Company Details Table 131. iBio, Inc. Description and Business Overview Table 132. iBio, Inc. COVID-19 Inactivated Vaccine Product Table 133. iBio, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 134. iBio, Inc. Recent Development Table 135. Moderna, Inc. Company Details Table 136. Moderna, Inc. Description and Business Overview Table 137. Moderna, Inc. COVID-19 Inactivated Vaccine Product Table 138. Moderna, Inc. Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 139. Moderna, Inc. Recent Development Table 140. Curevac Company Details Table 141. Curevac Description and Business Overview Table 142. Curevac COVID-19 Inactivated Vaccine Product Table 143. Curevac Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 144. Curevac Recent Development Table 145. ImmunoPrecise Company Details Table 146. ImmunoPrecise Description and Business Overview Table 147. ImmunoPrecise COVID-19 Inactivated Vaccine Product Table 148. ImmunoPrecise Revenue in COVID-19 Inactivated Vaccine Business 2020 and 2021 Table 149. ImmunoPrecise Recent Development Table 150. COVID-19 Inactivated Vaccine Market Trends Table 151. COVID-19 Inactivated Vaccine Market Drivers Table 152. COVID-19 Inactivated Vaccine Market Challenges Table 153. COVID-19 Inactivated Vaccine Market Restraints Table 154. Research Programs/Design for This Report Table 155. Key Data Information from Secondary Sources Table 156. Key Data Information from Primary Sources List of Figures Figure 1. Global COVID-19 Inactivated Vaccine Market Share by Type in 2021 & 2027 Figure 2. In Clinical Trials Features Figure 3. Out-of-Clinical Trials Features Figure 4. Global COVID-19 Inactivated Vaccine Market Share by Application in 2021 & 2027 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Other Case Studies Figure 8. COVID-19 Inactivated Vaccine Report Years Considered Figure 9. Global COVID-19 Inactivated Vaccine Market Size and Growth Rate (2020-2027) (US$ Million) Figure 10. Global COVID-19 Inactivated Vaccine Market Share by Regions (2020-2027) Figure 11. Global COVID-19 Inactivated Vaccine Market Share by Players in 2021 Figure 12. Global COVID-19 Inactivated Vaccine Market Size Market Share by Type (2021-2027) Figure 13. Global COVID-19 Inactivated Vaccine Market Size Market Share by Application (2021-2027) Figure 14. Global COVID-19 Inactivated Vaccine Revenue Market Share by Application in 2021 Figure 15. North America COVID-19 Inactivated Vaccine Market Size 2021-2027 (US$ Million) Figure 16. Europe COVID-19 Inactivated Vaccine Market Size 2021-2027 (US$ Million) Figure 17. Japan COVID-19 Inactivated Vaccine Market Size 2021-2027 (US$ Million) Figure 18. COVID-19 Inactivated Vaccine Market Size in China (2021-2027) (US$ Million) Figure 19. COVID-19 Inactivated Vaccine Market Size in Southeast Asia (2021-2027) (US$ Million) Figure 20. COVID-19 Inactivated Vaccine Market Size in India (2021-2027) (US$ Million) Figure 21. Bottom-up and Top-down Approaches for This Report Figure 22. Data Triangulation Figure 23. Key Executives Interviewed

Inovio Pharmaceuticals Takis Biotech (Evvivax) Zydus Cadila Codagenix, Inc. GeoVax, Inc. Bravovax Janssen Pharmaceutical Companies Altimmune Vaxart CanSino Biologics ExpreS2ion Biotechnologies ApS Clover Biopharmaceuticals GSK Vaxil Bio Ltd. Generex Novavax, Inc. Sanofi Pasteur Baylor iBio, Inc. Moderna, Inc. Curevac ImmunoPrecise